MeSH tree: C01.925.813.400
Hundreds of people in England who were unknowingly living with HIV are receiving a diagnosis and starting life-saving antiretroviral treatment, thanks to a pioneering NHS testing initiative rolled out in hospital emergency ...
11 hours ago
0
3
The national survey of 2,100 bi+ people—which includes identities like bisexual, pansexual, queer and fluid—provides crucial information to inform better health policy and services.
Jun 23, 2026
0
1
When many of us think about drug overdose, we picture young people at a music festival or people dependent on street heroin. But the latest figures from the Penington Institute show older Australians are increasingly dying ...
Jun 20, 2026
0
8
Women with HIV most often die from preventable, trauma-related conditions like substance use and mental illness—not the virus itself. Yet these leading causes are largely missing from official death records, according to ...
Jun 13, 2026
0
6
The 2025 executive order dismantling U.S. Agency for International Development programs canceled 90% of the agency's contracts and grants, destabilizing health systems globally.
Jun 12, 2026
0
4
Growing up witnessing the devastating effects of HIV in her family and community in South Africa pushed Olwam Plaatjie to start using preventive HIV medications three years ago.
Jun 9, 2026
0
3
A class of flu drugs may reduce cognitive decline and premature aging in people living with chronic viral infection, reports a new study led by Northwestern University that began with blood samples from people with HIV and ...
Jun 5, 2026
0
25
A recent University of Mississippi study has identified hundreds of counties in the South where HIV prevention and health care may not be keeping pace with the local needs, leaving communities without resources to address ...
Jun 3, 2026
0
3
Glucagon-like peptide-1 (GLP-1) receptor agonist medications have gained widespread attention for effectively treating obesity, lowering blood sugar and decreasing the risk of cardiovascular disease. Some researchers have ...
Jun 3, 2026
0
296
The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in South Africa from the United States in early April 2026. Clinical trials showed close to 100% efficacy. The rollout, ...
Jun 1, 2026
0
4
